Wvu Medicine Home Health United Hospital Center | |
2673 Davisson Run Road, Clarksburg, West Virginia 26301 | |
(800) 339-9896 | |
Name | Wvu Medicine Home Health United Hospital Center |
---|---|
Location | 2673 Davisson Run Road, Clarksburg, West Virginia |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 517053 |
Ownership Type | Voluntary Non-profit - Private |
Service Area Zip Codes | 24514, 25043, 25063, 25177, 25267, 25302, 25401, 25403, 25404, 25405, 25413, 25414, 25419, 25420, 25421, 25425, 25427, 25428, 25430, 25438, 25442, 25443, 25446, 25505, 25701, 25849, 26003, 26031, 26033, 26038, 26039, 26040, 26041, 26055, 26059, 26060, 26101, 26137, 26143, 26155, 26175, 26201, 26210, 26217, 26218, 26222, 26228, 26234, 26237, 26238, 26250, 26261, 26267, 26283, 26301, 26302, 26321, 26323, 26330, 26338, 26339, 26343, 26347, 26349, 26351, 26354, 26361, 26366, 26369, 26372, 26376, 26378, 26384, 26385, 26386, 26404, 26405, 26408, 26410, 26411, 26412, 26416, 26422, 26424, 26426, 26431, 26435, 26437, 26438, 26440, 26443, 26444, 26447, 26448, 26451, 26452, 26456, 26501, 26504, 26505, 26508, 26519, 26525, 26537, 26541, 26542, 26544, 26546, 26547, 26554, 26555, 26559, 26560, 26563, 26568, 26570, 26571, 26572, 26574, 26576, 26578, 26581, 26582, 26585, 26586, 26587, 26588, 26591, 26601, 26610, 26611, 26615, 26617, 26621, 26623, 26624, 26627, 26629, 26636, 26638, 26651, 26705, 26716, 26753, 26764, 26815 |
NPI Number | 1023638061 |
Organization Name | GATEWAY HOME CARE, LLC |
Doing Business As | ALLIED HEALTH SOLUTIONS HOME HEALTH |
Address | 2673 Davisson Run Rd, Clarksburg, WV 26301 |
Phone Number | 304-622-9458 |
News Archive
Pfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms.
The Washington Post reports that, despite an outbreak of fungal meningitis that took place 10 years ago and was linked to injections made by a compounding pharmacy in Massachusetts, not much has changed. Meanwhile, Politico adds that a recall of drugs related to the most recent round of illness could add to a critical drug shortage.
In recent decades much hope was based on the development of personalised drug treatments, in which genetic tests determine the choice and optimal dose of medication for each individual patient. However, the real breakthrough is still to be seen, and now researchers at Karolinska Institutet show in two separate scientific papers that many more gene variants affect how a person responds to medication than previously thought - and thus that today's analytical tools are too coarse.
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
› Verified 7 days ago
NPI Number | 1851906937 |
Organization Name | WVUHS HOME CARE, LLC |
Doing Business As | WVUHS HOME CARE |
Address | 2673 Davisson Run Rd, Clarksburg, WV 26301 |
Phone Number | 800-339-9896 |
News Archive
Pfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms.
The Washington Post reports that, despite an outbreak of fungal meningitis that took place 10 years ago and was linked to injections made by a compounding pharmacy in Massachusetts, not much has changed. Meanwhile, Politico adds that a recall of drugs related to the most recent round of illness could add to a critical drug shortage.
In recent decades much hope was based on the development of personalised drug treatments, in which genetic tests determine the choice and optimal dose of medication for each individual patient. However, the real breakthrough is still to be seen, and now researchers at Karolinska Institutet show in two separate scientific papers that many more gene variants affect how a person responds to medication than previously thought - and thus that today's analytical tools are too coarse.
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
› Verified 7 days ago
Quality Rating: |
News Archive
Pfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms.
The Washington Post reports that, despite an outbreak of fungal meningitis that took place 10 years ago and was linked to injections made by a compounding pharmacy in Massachusetts, not much has changed. Meanwhile, Politico adds that a recall of drugs related to the most recent round of illness could add to a critical drug shortage.
In recent decades much hope was based on the development of personalised drug treatments, in which genetic tests determine the choice and optimal dose of medication for each individual patient. However, the real breakthrough is still to be seen, and now researchers at Karolinska Institutet show in two separate scientific papers that many more gene variants affect how a person responds to medication than previously thought - and thus that today's analytical tools are too coarse.
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 97 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 98.8 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.8 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 58.2 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 69.9 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.8 | 96.4 |
News Archive
Pfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms.
The Washington Post reports that, despite an outbreak of fungal meningitis that took place 10 years ago and was linked to injections made by a compounding pharmacy in Massachusetts, not much has changed. Meanwhile, Politico adds that a recall of drugs related to the most recent round of illness could add to a critical drug shortage.
In recent decades much hope was based on the development of personalised drug treatments, in which genetic tests determine the choice and optimal dose of medication for each individual patient. However, the real breakthrough is still to be seen, and now researchers at Karolinska Institutet show in two separate scientific papers that many more gene variants affect how a person responds to medication than previously thought - and thus that today's analytical tools are too coarse.
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 83.2 | 79.6 |
How often patients got better at getting in and out of bed | 80.8 | 81.1 |
How often patients got better at bathing | 83.6 | 82.3 |
How often patients’ breathing improved | 81.3 | 82.8 |
How often patients’ wounds improved or healed after an operation | 95.4 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 76.8 | 75 |
How often home health patients had to be admitted to the hospital | 16.5 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.1 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 97.5 | 94 |
News Archive
Pfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms.
The Washington Post reports that, despite an outbreak of fungal meningitis that took place 10 years ago and was linked to injections made by a compounding pharmacy in Massachusetts, not much has changed. Meanwhile, Politico adds that a recall of drugs related to the most recent round of illness could add to a critical drug shortage.
In recent decades much hope was based on the development of personalised drug treatments, in which genetic tests determine the choice and optimal dose of medication for each individual patient. However, the real breakthrough is still to be seen, and now researchers at Karolinska Institutet show in two separate scientific papers that many more gene variants affect how a person responds to medication than previously thought - and thus that today's analytical tools are too coarse.
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Pfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms.
The Washington Post reports that, despite an outbreak of fungal meningitis that took place 10 years ago and was linked to injections made by a compounding pharmacy in Massachusetts, not much has changed. Meanwhile, Politico adds that a recall of drugs related to the most recent round of illness could add to a critical drug shortage.
In recent decades much hope was based on the development of personalised drug treatments, in which genetic tests determine the choice and optimal dose of medication for each individual patient. However, the real breakthrough is still to be seen, and now researchers at Karolinska Institutet show in two separate scientific papers that many more gene variants affect how a person responds to medication than previously thought - and thus that today's analytical tools are too coarse.
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
› Verified 7 days ago
The patient survey data of Wvu Medicine Home Health United Hospital Center is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 81 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 89 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 84 | 78 |
News Archive
Pfizer Inc has announced that the U.S. Food and Drug Administration (FDA) approved Toviaz (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms.
The Washington Post reports that, despite an outbreak of fungal meningitis that took place 10 years ago and was linked to injections made by a compounding pharmacy in Massachusetts, not much has changed. Meanwhile, Politico adds that a recall of drugs related to the most recent round of illness could add to a critical drug shortage.
In recent decades much hope was based on the development of personalised drug treatments, in which genetic tests determine the choice and optimal dose of medication for each individual patient. However, the real breakthrough is still to be seen, and now researchers at Karolinska Institutet show in two separate scientific papers that many more gene variants affect how a person responds to medication than previously thought - and thus that today's analytical tools are too coarse.
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
› Verified 7 days ago
Wvu Medicine Home Health United Hospital Center Location: 2673 Davisson Run Road, Clarksburg, West Virginia 26301 Ratings: Phone: (800) 339-9896 |